LIQUICHEK URINE CHEMISTRY CONTROL MINIPAK

Description of Event or Problem

ON (B)(6) 2025, A CHEMISTRY LAB SUPERVISOR AT (B)(6), USA REPORTED AN EYE SPLASHING EVENT ON THEIR COLLEAGUE AT (B)(6) CENTER IN (B)(6). ON (B)(6) 2025, A MEDICAL TECHNOLOGIST SPLASHED LIQUID IN THE EYES WHEN THROWING RACKS OF QC MATERIALS IN THE TRASH BIN. IT WAS REPORTED THAT ROCHE REAGENTS WERE ALSO INCLUDED ON THE RACK. THE RACK HIT THE TRASH AND LIQUID SPLASHED BACK IN THEIR EYES. THE MEDICAL TECHNOLOGIST IMMEDIATELY WENT TO THE EYEWASH STATION FOR 10 MINUTES AND THEN TO THE EMERGENCY DEPARTMENT TO CHECK THE EYES. THE EMERGENCY DEPARTMENT DETERMINED THAT THERE WAS NO HARM TO THE MEDICAL TECHNOLOGIST AND PRESCRIBED ANTIBIOTICS FOR PRECAUTIONS. NO ADDITIONAL MEDICAL ATTENTION WAS REQUIRED. THE FOLLOWING QC PRODUCTS WERE REPORTED FOR THIS EVENT: LIQUICHEK ETHANOL/AMMONIA CONTROL, LOT: 54430, LIQUICHEK IMMUNOLOGY CONTROL, LOT: 85740, LIQUICHEK URINE CHEMISTRY CONTROL, LOT: 97450, LIQUICHEK CARDIAC TROPONINS CONTROL, LOT: 89091, LIQUICHEK CARDIAC TROPONINS CONTROL, LOT: 89092, LIQUICHEK CARDIAC TROPONINS CONTROL, LOT: 89093, LIQUID UNASSAYED MULTIQUAL, LOT: 56720, LIQUICHEK SPINAL FLUID CONTROL, LOT: 56540, LYPHOCHEK IMMUNOASSAY PLUS CONTROL, LOT: 40440. NO SAFETY GLASSES WERE WORN AT THE TIME OF THE EVENT. THE EMPLOYEE AND FACILITY HAD PRODUCT'S INSTRUCTIONS FOR USE (IFU) AND SAFETY DATA SHEET (SDS) AND WERE PROVIDED WITH CERTIFICATE OF ANALYSIS FOR ALL THESE PRODUCTS.

Additional Manufacturer Narrative

INSTRUCTION FOR USE (IFU) PROVIDED BY BIO-RAD FOR TESTING LIQUICHEK URINE CHEMISTRY CONTROL INDICATES THAT THE PRODUCT CONTAINS HUMAN SOURCE MATERIALS AND SHOULD BE CONSIDERED POTENTIALLY INFECTIOUS AND HANDLED WITH THE SAME PRECAUTIONS USED WITH PATIENT SPECIMENS IN ACCORDANCE WITH GOOD LABORATORY PRACTICE. EACH HUMAN DONOR UNIT USED TO MANUFACTURE THIS PRODUCT WAS TESTED AS REQUIRED BY FDA ACCEPTED METHODS. TESTS RESULTS WERE NON-REACTIVE OR NEGATIVE FOR EVIDENCE OF INFECTION DUE TO HUMAN IMMUNODEFICIENCY VIRUS (HIV), HEPATITIS B VIRUS (HBV) AND HEPATITIS C VIRUS (HCV). THIS PRODUCT MAY ALSO CONTAIN OTHER HUMAN SOURCE MATERIALS FOR WHICH THERE ARE NO APPROVED TESTS. IN ACCORDANCE WITH GOOD LABORATORY PRACTICE, ALL HUMAN SOURCE MATERIAL SHOULD BE CONSIDERED POTENTIALLY INFECTIOUS AND HANDLED WITH THE SAME PRECAUTIONS USED WITH PATIENT SPECIMENS. THE IFU ALSO INDICATES THAT CAUTION SHOULD BE USED WHEN HANDLING THIS PRODUCT TO PREVENT SPLASHING AND INSTRUCTS THE USER TO WEAR APPROPRIATE EYE/FACE PROTECTION WHEN USING THIS PRODUCT TO PROTECT FROM SPLASHES.